Ecolab (ECL) Q4 2024 earnings summary

Executive summary

• Achieved record 2024 performance with strong organic sales growth, margin expansion, and robust free cash flow, led by U.S. growth and new business wins globally.

• Reported diluted EPS was $1.66 (+18%) and adjusted diluted EPS was $1.81 (+17%) in Q4; full-year adjusted EPS reached $6.65.

• Focused on innovation, digital transformation, and new growth engines such as data centers, microelectronics, and life sciences.

• Confident 2025 outlook with double-digit adjusted EPS growth expected.

Financial highlights

• Q4 2024 organic sales grew 4% to $4,021.5M; reported sales up 2% to $4,005.2M.

• Q4 adjusted diluted EPS was $1.81 (+17%); reported diluted EPS $1.66 (+18%).

• Q4 organic operating income margin was 17.4% (+150 bps); gross margin expanded to 43.4%.

• Full-year 2024 net sales were $15.7 billion (+3%); free cash flow reached $1.8 billion.

• Cash from operations for 2024 was $2,813.9M, up from $2,411.8M in 2023.

Outlook and guidance

• 2025 adjusted diluted EPS expected in the $7.42–$7.62 range (+12% to 15%), including a 4% currency headwind.

• Q1 2025 adjusted diluted EPS expected at $1.47–$1.53 (+10% to 14%), also including a 4% currency headwind.

• Targeting 20% operating income margin by 2027, with confidence in crossing 18% in 2025.

• Organic sales growth expected to slightly exceed 4% in 2025, with volume growth around 2% and value pricing contributing 2%-3%.

• CapEx to sales ratio projected at 7% in 2025, with continued investment in digital and high-tech initiatives.